Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SMCI vs GSK✓SelectedUSD · GSKSMCI vs GSK performance historyLatest closeAs of-9.19%11/20
Stock and ETF performance explorer

SMCI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+718.5%
GSK return
+97.4%
Excess return
+621.1%
Maximum drawdown
-84.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-9.2%-0.1%-9.1%-9.1%
7D-19.4%-5.3%-14.1%-17.8%
30D-39.1%-3.7%-35.5%-38.5%
3M-40.7%-7.3%-33.4%-39.4%
6M-35.3%-4.2%-31.1%-35.6%
YTD-26.0%+0.9%-26.9%-27.8%
1Y-31.4%+7.3%-38.7%-34.8%
3Y-28.9%+52.7%-81.7%-44.6%
5Y+413.3%+40.1%+373.2%+305.8%
All+718.5%+97.4%+621.1%+439.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling